Reports indicate that hormetic ePads provide durable symptomatic relief for individuals diagnosed with "Shingles" and genital herpes. We are sponsoring a confirmation trial for ten individuals. Participant requirements:

1. Active lesions at entry;
2. Willingness to provide before, during and after digital photographs of lesions;
3. Grant us permission to use these photographs;
4. Sign an informed consent for use of experimental technology;
5. Use pads as directed on lesion areas;
6. Contact@dshedu.com or dial 970 372-4274, (Jim), to participate.

ePads may be pinned or stitched inside clothing, or held in place with a cloth or ace bandage. The pads retain their potency for over 100 years, and are durable and washable. They are designed so that a single 3 by 5 inch pad should serve a lifetime.

Users report reversal of lesion symptoms if pad is applied before outbreak occurs. They also report shingle symptoms begin reversing within three hours of ePad application.

ePad hormetic bandages emit electrons which appear to disrupt the lifecycle of a wide range of pathogenic organisms. The mode of action is unknown, but appears to be related to interruption of the inflammatory process which enables symptoms. The presentation below suggests mechanisms for this action, with elevated lipid conjugation, and peroxidation, during incubation while the pathogens are more vulnerable.

This presentation describes the ePad technology and suggests several reasons why we think it works. Find ePad Products, or contact us at 970 372 4274. ePads are an experimental technology, and are not covered by insurance

Find ePads